Showing results (11-20 of 59) with videos related to
Sort By:
Pageof 6
Journal of Clinical Epidemiology|July 5, 2015
Multivariate meta-analysis of individual participant data helped externally validate the performance and implementation of a prediction modelKym I E Snell, Harry Hua, Thomas P A Debray, et al.Pharmacogenomics|July 30, 2016
Opioid treatment failure in cancer patients: the role of clinical and genetic factorsAstrid W Oosten, Maja Matic, Ron H van Schaik, et al.Cancer Research|July 3, 2004
Urokinase-type plasminogen activator system in breast cancer: association with tamoxifen therapy in recurrent diseaseMarion E Meijer-van Gelder, Maxime P Look, Harry A Peters, et al.Molecular and Cellular Endocrinology|August 22, 2007
Polymorphic variations in exon 10 of the luteinizing hormone receptor: functional consequences and associations with breast cancerDjura Piersma, Miriam Verhoef-Post, Maxime P Look, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic responseHerman Burger, John A Foekens, Maxime P Look, et al.Endocrine-Related Cancer|January 18, 2014
LAMP3 is involved in tamoxifen resistance in breast cancer cells through the modulation of autophagyAnika Nagelkerke, Anieta M Sieuwerts, Johan Bussink, et al.Statistics in Medicine|March 26, 2021
Individual participant data meta-analysis for external validation, recalibration, and updating of a flexible parametric prognostic modelJoie Ensor, Kym I E Snell, Thomas P A Debray, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 23, 2006
Primary tumor levels of tissue inhibitor of metalloproteinases-1 are predictive of resistance to chemotherapy in patients with metastatic breast cancerAnne-Sofie Schrohl, Marion E Meijer-van Gelder, Mads N Holten-Andersen, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 8, 2015
Clinical Relevance of Targeting the Gastrin-Releasing Peptide Receptor, Somatostatin Receptor 2, or Chemokine C-X-C Motif Receptor 4 in Breast Cancer for Imaging and TherapySimone U Dalm, Anieta M Sieuwerts, Maxime P Look, et al.Breast Cancer Research : BCR|December 3, 2010
Clinical significance of the nuclear receptor co-regulator DC-SCRIPT in breast cancer: an independent retrospective validation studyAnieta M Sieuwerts, Marleen Ansems, Maxime P Look, et al.Pageof 6